In the BioHarmony Drug Report Database

"Preview" Icon

Oxcarbazepine

Oxtellar, Trileptal (oxcarbazepine) is a small molecule pharmaceutical. Oxcarbazepine was first approved as Oxtellar on 2000-01-14. It is used to treat epilepsy and partial epilepsies in the USA. Trileptal’s patent is valid until 2027-04-13 (FDA).

 

Trade Name

 

Oxtellar, Trileptal
 

Common Name

 

oxcarbazepine
 

ChEMBL ID

 

CHEMBL1068
 

Indication

 

epilepsy, partial epilepsies
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Oxcarbazepine structure rendering